Literature DB >> 10847438

Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea.

S H Lee1, H J Kim, S K Yang, W H Kim, Y S Joo, S H Dong, B H Kim, J I Lee, Y W Chang, R Chang.   

Abstract

BACKGROUND: Decreased bone mineral density (BMD) is common in Western patients with inflammatory bowel disease (IBD). However, BMD has never been studied in Asia where the demographic and socio-economic status are different from the West. The aim of this study was to investigate the prevalence and mechanisms of osteopenia in newly diagnosed Korean patients with IBD.
METHODS: We studied 14 patients with Crohn's disease (CD) and 25 patients with ulcerative colitis (UC), all of whom had never been treated with corticosteroids. Bone mineral density was measured in the lumbar spine and the femoral neck by dual energy X-ray absorptiometry. Biochemical parameters including serum osteocalcin, parathyroid hormone, plasma inactive and active vitamin D, and urinary deoxypyridinoline were measured.
RESULTS: The BMD Z score at the lumbar spine was lower both in CD and in UC patients, but there was no significant difference between the two groups. There was no significant difference in nutritional status or biochemical parameters of bone metabolism between patients with a normal BMD and those with a decreased BMD.
CONCLUSIONS: Low BMD at the lumbar spine is common in newly diagnosed Korean patients with IBD, a result which is similar to Western studies. The mechanism for low bone mass remains undetermined; however, nutritional status and hormonal parameters of bone metabolism, and ethnic differences are not likely to be an important factor in the pathogenesis of this bone loss.

Entities:  

Mesh:

Year:  2000        PMID: 10847438     DOI: 10.1046/j.1440-1746.2000.02154.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.

Authors:  Levent Ediz; Ahmet Cumhur Dülger; Murat Toprak; Mehmet Fethi Ceylan; Ozgür Kemik
Journal:  Int J Clin Exp Med       Date:  2011-04-03

2.  CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin.

Authors:  F R Byrne; S Morony; K Warmington; Z Geng; H L Brown; S A Flores; M Fiorino; S L Yin; D Hill; V Porkess; D Duryea; J K Pretorius; S Adamu; R Manoukian; R Manuokian; D M Danilenko; I Sarosi; D L Lacey; P J Kostenuik; G Senaldi
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.

Authors:  Toufic A Kabbani; Ioannis E Koutroubakis; Robert E Schoen; Claudia Ramos-Rivers; Nilesh Shah; Jason Swoger; Miguel Regueiro; Arthur Barrie; Marc Schwartz; Jana G Hashash; Leonard Baidoo; Michael A Dunn; David G Binion
Journal:  Am J Gastroenterol       Date:  2016-03-08       Impact factor: 10.864

4.  Bone mineral density in Iranian patients with inflammatory bowel disease.

Authors:  Mohammadreza Zali; Ali Bahari; Farzad Firouzi; Nasser Ebrahimi Daryani; Rahim Aghazadeh; Mohammad Mehdi Emam; Ali Rezaie; Hamid Mohaghegh Shalmani; Nosratollah Naderi; Baharak Maleki; Alireza Sayyah; Mohammad Bashashati; Haniehsadat Jazayeri; Shima Zand
Journal:  Int J Colorectal Dis       Date:  2006-02-04       Impact factor: 2.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.